02212nam a2200433 a 4500003492590MiAaHDL20250726000000.0m d cr bn ---auaua000717s1992 dcuad b f000 0 eng d(MiU)990034925900106381sdr-miu.990034925900106381(MiU)MIU01000000000000003492590-goog(OCoLC)25387496(MiU)Aleph003492590GAOGAOEYMUtOrBLWn-us---GA 1.13:PEMD-92-9B-246187GAO/PEMD-92-9KF3894.O85A35United States.General Accounting Office.http://id.loc.gov/authorities/names/n80126064http://id.loc.gov/rwo/agents/n80126064Nonprescription drugs :over the counter and underemphasized : report to the Chairman, Subcommittee on Regulation, Business Opportunities, and Energy, Committee on Small Business, House of Representatives /United States General Accounting Office.Over the counter and underemphasized, nonprescription drugsWashington, D.C. :The Office ;Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20877) :U.S. General Accounting Office [distributor],[1992]15 p. :ill., chart ;28 cmtexttxtrdacontentunmediatednrdamediavolumencrdacarrier"B-246187"--P. 1."GAO/PEMD-92-9.""January 1992."Cover title.Includes bibliographical references (14-15).Mode of access: Internet.United States.Food and Drug AdministrationRules and practice.United States.Food and Drug AdministrationAuditing.Nonprescription Drugs.http://id.nlm.nih.gov/mesh/D004366Drugs, NonprescriptionSide effects.Drugs, NonprescriptionLaw and legislationUnited StatesEvaluation.United States.Congress.House.Committee on Small Business.Subcommittee on Regulation, Business Opportunities, and Energy.http://id.loc.gov/authorities/names/no89011202http://id.loc.gov/rwo/agents/no8901120239015022612793Buhr B 150787100349259020241218061404.020250726000000.020260314165432.02026-03-15T08:37:13Z2026-01-01T18:30:02ZSDR-MIUmiuALMAprepare.pl-004-009BKsdr-miu.990034925900106381MiUSDRMIU003492590mdp.39015022612793MIU990034925900106381MIUMIU20260315googlemdp.390150226127931992pdbibUS fed doc